Lithuania and Poland negotiate joint drug packaging agreement

19 July 2012

In a high level meeting, government officials from Lithuania and Poland explored the possibility to legalize drug packaging in both Lithuanian and Polish, reports, europe-health-care.eu

The agreement would allow drugs with both Polish and Lithuanian labels onto the Lithuanian market. According to Lithuanian government officials, drug shortages occur due the requirement for package inserts to be translated in the language of the market they are placed on.

As the Lithuanian drug market is relatively small it is expensive for drugmakers to translate package inserts into Lithuanian. Given these considerations, the Lithuanian health authorities expect prices to drop and get access to more drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical